Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-079-8 | CAS number: 75147-23-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24.08 - 01.10.1998
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- not specified
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The Maximisation test was selected because it is regarded as the most sensitive and the preferred method with regard to testing for sensitisation potential.
Test material
- Reference substance name:
- 1,5-dimethylbicyclo[3.2.1]octan-8-one oxime
- EC Number:
- 278-079-8
- EC Name:
- 1,5-dimethylbicyclo[3.2.1]octan-8-one oxime
- Cas Number:
- 75147-23-8
- Molecular formula:
- C10H17NO
- IUPAC Name:
- N-[(8E)-1,5-dimethylbicyclo[3.2.1]octan-8-ylidene]hydroxylamine
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Germany
- Age at study initiation: 7 weeks
- Weight at study initiation: <500 g
- Housing: 5 animals in 1 metal cage with wire-mesh floors and equipped with an automatic drinking system (ITL, Bergen, The Netherlands)
- Diet: Free access to standard guinea pig diet, including ascorbic acid (1600 mg/kg); LC 23-B, pellet diameter 4mm (Hope farms, Woerden, The Netherlands).
- Water: Free access to tap-water, diluted with decalcified water
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 2
- Humidity (%): 45 - 55
- Air changes (per hr): 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours daily, from 7.00 a.m. to 7.00 p.m.
- Lighting: Fluorescent light, 4000°K, 120 Lux
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- corn oil
- Concentration / amount:
- 0.1%
Challengeopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- corn oil
- Concentration / amount:
- 0.1%
- No. of animals per dose:
- 10
- Details on study design:
- PRELIMINARY STUDY
- Justification: to select the test concentrations to be used in the main study
- Test substance concentrations: 50, 20, 10, 5, 2, 1 and 0%.
- Method: identical to those during the main study
- Intradermal injections: 2 animals received 2 different concentrations in duplicate (0.1 ml/site) in the clipped scapular region; assessment for irritation 24 and 48 hours after treatment.
- Epidermal application: 2 different concentrations were applied per animal to the clipped flank, using Metallive patches on Medical tape, held in place with Micropore tape and subsequently Coban elastic bandage. After 24 hours, the dressing was removed and the skin cleaned of residual test substance. The treated skin areas were assessed for irritation 24 and 48 hours after exposure.
MAIN STUDY
INDUCTION
- 3 pairs of intradermal injections (0.1 mL/site): 1:1 w/w mixture of Freunds' Complete Adjuvant with water for injection; undiluted test substance; 1:1 w/w mixture of the undiluted test substance and Freunds' Complete Adjuvant.
- Exposure period: 24 hours
- Site: clipped area: 2 x 3 cm
CHALLENGE
- No. of exposures: 1
- Exposure period: 24 hours
- Site: Metalline patches (2x3 cm) mounted on Medical tape, which were held in place with Micropore tape and subsequently Coban elastic bandage.
- Concentrations: 0,5 mL
- Evaluation (hr after challenge): 24 and 48 hours: Any signs of erythema and other lesions were recorded.
RE-CHALLENGE
- one week after the first challenge: to clarify the results in the first challenge. The contralateral flank of all animals was similarly treated.
OTHER:
- Randomization: by way of lottery drawing
- Controle group: 10 animals were treated as described for the experimental animals, except that the vehicle was administered.
OBSERVATIONS:
- Mortality: twice daily
- Body weights: Prior to start and at termination of the study.
- Irritation: Skin reactions were graded according to the following numerical scoring systems. Furthermore, a description of all other (local) effects was recorded. Whenever necessary, the treated skin-areas were clipped at least 3 hours before the next skin reading to facilitate scoring.
GRADING IRRITATION REACTIONS
ERYTHEMA AND ESCHAR FORMATION
0: no erythema
1: slight erythema (barely perceptible)
2: well defined erythema
3: moderate to severe erythema
4: severe erythema (beet redness) to slight eschar formation (injuries in depth)
OEDEMA FORMATION
0: no oedema
1: very slight oedema (barely perceptible)
2: slight oedema (edges of area well defined by definite raising)
3: moderate oedema (raised approximately 1 mm)
4: severe oedema (raised more than 1 mm and extending beyond area of exposure)
GRADING CHALLENGE REACTIONS
0: no visible change
1: Discrete or patchy erythema
2: Moderate and confluent erythema
3: Moderate erythema and swelling
4: Intense erythema and swelling
At the end of the study all animals were killed by asphyxiation using an oxygen/carbon dioxide procedure. - Positive control substance(s):
- not specified
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No skin reactions
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No skin reactions.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No skin reactions
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No skin reactions.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The test item is not sensitising under the conditions of the current study.
- Executive summary:
The purpose of this study was to evaluate whether the test item induces contact hypersensitivity in guinea pigs after intradermal and epidermal exposure of the animals under the conditions described in this report.
The Maximisation test is selected because it is regarded as the most sensitive and the preferred method with regard to testing for sensitisation potential.
The study was carried out based on the guidelines described in EC Commission Directive 96/54/EC, Part B.6, 'Skin Sensitisation" and OECD No. 406, "Skin Sensitisation", and based on the method described by Magnusson and Kligman.
The test substance concentrations selected for the main study were based on the results of a preliminary study. In the main study, 10 animals were intradermally injected with the undiluted test substance and epidermally exposed to the undiluted test substance. Five control animals were similarly treated, but with the vehicle only. Two weeks after the epidermal application all animals were challenged with the undiluted test substance and the vehicle. A second challenge was performed one week later with again the undiluted test substance and the vehicle.
In the first challenge a skin reaction of grade 1 (score 1 accounts for the left side area of the application site) was observed in 1 animal in response to the undiluted test substance concentration, 48 hours after exposure. No skin reactions were evident in the control animals.
In the second challenge, performed one week later, no skin reactions were evident after the challenge exposure in the experimental and control animals.
The skin reaction of grade 1, observed in response to the undiluted test substance in 1 animal in the first challenge phase, is equal to 10% of the animals responding. According to the criteria set out in Annex I (Table 3.4.4.) of the CLP Regulation N° 1272/2008 the substance does not have to be classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.